Article info
Cardiac risk factors and prevention
Original article
Dabigatran etexilate and reduction in serum apolipoprotein B
- Correspondence to Dr Philip G Joseph, Population Health Research Institute, C2 6A DB-CVSRI, 237 Barton St East, Hamilton, Ontario, Canada L8L 2X2; philip.joseph{at}phri.ca
Citation
Dabigatran etexilate and reduction in serum apolipoprotein B
Publication history
- Received March 18, 2015
- Revised July 22, 2015
- Accepted August 19, 2015
- First published November 9, 2015.
Online issue publication
December 11, 2015
Article Versions
- Previous version (9 November 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/